LinLin Qian - 24 Sep 2025 Form 4 Insider Report for Health In Tech, Inc. (HIT)

Role: Chief Financial Officer, Director, 10%+ Owner
Signature: /s/ LinLin Qian
Issuer symbol: HIT
Transactions as of: 24 Sep 2025
Net transactions value: $0
Form type: 4
Filing time: 26 Sep 2025, 19:19:00 UTC
Previous filing: 19 Aug 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Qian LinLin	Chief Financial Officer, Director, 10%+ Owner	701 S. COLORADO AVE,, SUITE 1, STUART	/s/ LinLin Qian	26 Sep 2025	0001849454

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HIT	Class A Common Stock	Award	$0	+80,000	+0.99%	$0.000000	8,128,555	24 Sep 2025	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. One third (1/3) of the shares of restricted stock granted to the reporting person shall vest in equal monthly installments over a twelve (12) month period commencing on the date a letter of intent or memorandum of understanding is signed in connection with an initiative being developed by the Company (the "Initiative"), one third (1/3) of the shares shall vest in equal monthly installments over a twelve (12) month period commencing on the date the Initiative enters proof-of-concept or beta launch, and, the remaining one third (1/3) of the shares shall vest in equal monthly installments over a twelve (12) month period commencing on the date of full commercial launch of the Initiative.
F2	Includes 130,495 shares of restricted stock and 7,998,060 shares of Class A Common Stock. Excludes 2,700,000 shares of Class B Common Stock and 711,510 options to purchase shares of Class A Common Stock.

Content

Represents restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. One third (1/3) of the shares of restricted stock granted to the reporting person shall vest in equal monthly installments over a twelve (12) month period commencing on the date a letter of intent or memorandum of understanding is signed in connection with an initiative being developed by the Company (the "Initiative"), one third (1/3) of the shares shall vest in equal monthly installments over a twelve (12) month period commencing on the date the Initiative enters proof-of-concept or beta launch, and, the remaining one third (1/3) of the shares shall vest in equal monthly installments over a twelve (12) month period commencing on the date of full commercial launch of the Initiative.

Includes 130,495 shares of restricted stock and 7,998,060 shares of Class A Common Stock. Excludes 2,700,000 shares of Class B Common Stock and 711,510 options to purchase shares of Class A Common Stock.